Raquel Longarón

854 total citations
37 papers, 593 citations indexed

About

Raquel Longarón is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Raquel Longarón has authored 37 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Raquel Longarón's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (11 papers) and Kruppel-like factors research (9 papers). Raquel Longarón is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (11 papers) and Kruppel-like factors research (9 papers). Raquel Longarón collaborates with scholars based in Spain, United States and United Kingdom. Raquel Longarón's co-authors include Beatríz Bellosillo, Alberto Álvarez‐Larrán, Luz Martínez‐Avilés, Joan Maurel, Anna Angona, Pere Gascón, Lara Pijuán, Rosa Gallego, Edurne Arriola and Marta Salido and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Raquel Longarón

37 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raquel Longarón Spain 14 242 224 222 200 166 37 593
Claire Villalva France 15 289 1.2× 246 1.1× 164 0.7× 136 0.7× 126 0.8× 20 601
Juergen Mestan Switzerland 4 184 0.8× 436 1.9× 161 0.7× 73 0.4× 81 0.5× 11 667
Joana Vieira Portugal 14 220 0.9× 344 1.5× 134 0.6× 293 1.5× 42 0.3× 39 701
Jesse McGreivy United States 12 339 1.4× 335 1.5× 117 0.5× 176 0.9× 185 1.1× 41 697
Sam Agresta United States 15 121 0.5× 474 2.1× 315 1.4× 127 0.6× 285 1.7× 27 912
Stephen Castaneda United States 10 356 1.5× 217 1.0× 83 0.4× 143 0.7× 96 0.6× 14 685
Matthew S. Zabriskie United States 9 170 0.7× 307 1.4× 70 0.3× 142 0.7× 301 1.8× 24 720
Arthur A. Glatfelter United States 10 114 0.5× 218 1.0× 80 0.4× 324 1.6× 124 0.7× 14 615
Mirjam F. Mastik Netherlands 14 175 0.7× 233 1.0× 118 0.5× 283 1.4× 40 0.2× 28 656
C. Ormazábal Spain 9 159 0.7× 283 1.3× 204 0.9× 85 0.4× 48 0.3× 12 498

Countries citing papers authored by Raquel Longarón

Since Specialization
Citations

This map shows the geographic impact of Raquel Longarón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel Longarón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel Longarón more than expected).

Fields of papers citing papers by Raquel Longarón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel Longarón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel Longarón. The network helps show where Raquel Longarón may publish in the future.

Co-authorship network of co-authors of Raquel Longarón

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel Longarón. A scholar is included among the top collaborators of Raquel Longarón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel Longarón. Raquel Longarón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández‐Rodríguez, Concepción, Blanca Sánchez‐González, Raquel Longarón, et al.. (2024). Genetic Characterization of Marginal Zone Lymphomas in Tissue and cfDNA. Blood. 144(Supplement 1). 4351–4351. 1 indexed citations
2.
Álvarez, Pilar, Beatríz Bellosillo, Francesc Colom, et al.. (2023). Y-chromosome in the olfactory neuroepithelium as a potential biomarker of depression in women with male offspring: an exploratory study. Molecular and Cellular Biochemistry. 479(6). 1451–1455. 1 indexed citations
3.
Chalela, Roberto, Víctor Curull, Albert Sánchez‐Font, et al.. (2021). EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma. Pathology & Oncology Research. 27. 598292–598292. 1 indexed citations
4.
Taus, Álvaro, Pedro Rocha, Ainhoa Hernández, et al.. (2020). Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma. Archivos de Bronconeumología. 57(5). 323–329. 2 indexed citations
5.
Prieto‐Potín, Iván, Rebeca Manso, Cristina Chamizo, et al.. (2020). Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignancies. PeerJ. 8. e10069–e10069. 1 indexed citations
6.
Taus, Álvaro, Pedro Rocha, Lara Pijuán, et al.. (2018). Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma. Clinical Lung Cancer. 19(5). 387–394.e2. 44 indexed citations
7.
Sánchez‐Font, Albert, Roberto Chalela, Clara Martín‐Ontiyuelo, et al.. (2018). Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy‐guided bronchoscopy. Cancer Cytopathology. 126(10). 860–871. 11 indexed citations
8.
Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2017). P1.02-048 MET Exon 14 Skipping Mutations and Gene Amplifications Are Not Simultaneous Events in NSCLC. Journal of Thoracic Oncology. 12(1). S516–S517. 1 indexed citations
9.
Senín, Alicia, Concepción Fernández‐Rodríguez, Beatríz Bellosillo, et al.. (2017). Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up. Annals of Hematology. 97(3). 443–451. 35 indexed citations
10.
Taus, Álvaro, Ainhoa Hernández, Eva López, et al.. (2017). P1.02-039 Assessment of KRAS mutations (by Digital PCR) in Circulating Tumoral DNA from Lung Adenocarcinoma Patients. Journal of Thoracic Oncology. 12(1). S511–S511. 1 indexed citations
11.
Angona, Anna, Alberto Álvarez‐Larrán, Beatríz Bellosillo, et al.. (2016). Characterization of CD34+ hematopoietic progenitor cells in JAK2 V617F and CALR -mutated myeloproliferative neoplasms. Leukemia Research. 48. 11–15. 6 indexed citations
12.
Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2016). 11P Prognostic impact of MET mutations in exon 14 and copy number alterations in a series of NSCLC patients. Journal of Thoracic Oncology. 11(4). S61–S61. 1 indexed citations
13.
Navarro, Alfons, Silvia Pairet, Aina Pons, et al.. (2016). miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia. Blood Cancer Journal. 6(3). e406–e406. 23 indexed citations
14.
Angona, Anna, Alberto Álvarez‐Larrán, Beatríz Bellosillo, et al.. (2014). Trombocitemia esencial: características iniciales y factores de riesgo de supervivencia y trombosis en una serie de 214 pacientes. Medicina Clínica. 144(6). 247–253. 5 indexed citations
15.
Martínez‐Avilés, Luz, Alberto Álvarez‐Larrán, Carles Besses, et al.. (2012). Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia. Annals of Hematology. 91(10). 1555–1562. 6 indexed citations
16.
Besses, Carlos, Alberto Álvarez‐Larrán, Luz Martínez‐Avilés, et al.. (2011). Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients. British Journal of Haematology. 152(4). 413–419. 17 indexed citations
17.
Salido, Marta, Lara Pijuán, Luz Martínez‐Avilés, et al.. (2010). Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(1). 21–27. 129 indexed citations
18.
Florensa, Lourdes, Beatríz Bellosillo, Leonor Arenillas, et al.. (2010). LY2784544, a Novel JAK2 Inhibitor, Decreases In Vitro Growth of Hematopoietic Human Progenitors From JAK2 V617F Positive Polycythemia Vera Patients. Blood. 116(21). 5054–5054. 3 indexed citations
19.
García‐Albéniz, Xabier, Estela Pineda, Laura Visa, et al.. (2009). Serum Matrilysin Levels Predict Outcome in Curatively Resected Colorectal Cancer Patients. Annals of Surgical Oncology. 16(5). 1412–1420. 21 indexed citations
20.
Maurel, Joan, Cristina Nadal, Xabier García‐Albéniz, et al.. (2007). Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. International Journal of Cancer. 121(5). 1066–1071. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Villalva Breakdown of academic impact, for papers by Juergen Mestan Breakdown of academic impact, for papers by Joana Vieira Breakdown of academic impact, for papers by Jesse McGreivy Breakdown of academic impact, for papers by Sam Agresta Breakdown of academic impact, for papers by Stephen Castaneda Breakdown of academic impact, for papers by Matthew S. Zabriskie Breakdown of academic impact, for papers by Arthur A. Glatfelter Breakdown of academic impact, for papers by Mirjam F. Mastik Breakdown of academic impact, for papers by C. Ormazábal
Rankless by CCL
2026